Streetbeat News

Products Services

NVO

Novo Nordisk's parent company is nearing the completion of a significant manufacturing deal, which could enhance its production capabilities. This development is a positive step for the company, potentially impacting its operations and market position.

Portfolio Pulse from

December 11, 2024 | 2:30 pm

FUBO

FuboTV (FUBO) shares have fallen 46% year-to-date due to competition and legal challenges. However, the company shows potential with strong streaming demand and innovative offerings.

Portfolio Pulse from

December 11, 2024 | 2:30 pm

GM

General Motors is halting its Cruise robotaxi project to focus on driver assistance and core vehicle production, allowing reinvestment in its EV division or returning cash to shareholders.

Portfolio Pulse from

December 11, 2024 | 2:30 pm

ABBV

AbbVie has completed its acquisition of Aliada Therapeutics, enhancing its neuroscience pipeline with a promising Alzheimer's therapy and novel BBB-crossing technology.

Portfolio Pulse from

December 11, 2024 | 2:30 pm

VEON

VEON Ltd. has partnered with Kazakh research institutions to launch an open-source Kazakh-language large language model (Kaz-LLM). This initiative is coordinated by Kazakhstan's Ministry of Digital, Innovations, and Aerospace Industry and involves the Institute of Smart Systems and Artificial Intelligence at Nazarbayev University, VEON's QazCode, Beeline Kazakhstan, and the Astana Hub.

Portfolio Pulse from

December 11, 2024 | 2:30 pm

IHRT

TTD

iHeartMedia has adopted Unified ID 2.0, an open-source identity framework from The Trade Desk, to enhance its audio advertising capabilities. This integration aims to provide better targeting, measurement, and attribution for advertisers.

Portfolio Pulse from

December 11, 2024 | 2:30 pm

GLOB

Faros AI and Globant have announced a partnership aimed at improving software development lifecycle (SDLC) efficiency through AI-powered insights. This collaboration is expected to enhance team performance, productivity, and business outcomes.

Portfolio Pulse from

December 11, 2024 | 2:15 pm

HLLK

Jubilee Intel, a subsidiary of Hallmark Venture Group, Inc. (OTC: HLLK), has expanded its operations to Europe, Asia, and Latin America, enhancing its analytics platform to better serve its international clients.

Portfolio Pulse from

December 11, 2024 | 2:15 pm

SXTP

60 Degrees Pharmaceuticals is expanding its clinical trial for tafenoquine, a treatment for babesiosis, to Brigham and Women's Hospital. This trial addresses a critical unmet medical need.

Portfolio Pulse from

December 11, 2024 | 2:15 pm